Human element [ hs1775 ]Position: chr11:2,395,417-2,396,757 (UCSC browser) Source: Lawrence Berkeley National Laboratory Flanking genes: CD81-AS1(intragenic) Timepoints: e11.5 This sequence did not show observable enhancer activities at E11.5 We define a negative enhancer at this developmental stage when at least 3 transgenics were obtained and yet no reproducible pattern of expression was observed. This does not mean that this sequence is not an enhancer at another time point or a weak enhancer at this time point but below the detectable range at our level of resolution. Fasta sequence gcgtGTCTGCCCAAGATGAGTGCTagtggccgactccctgctagagtgagcactgcataa acagcctctgcttgtcctcatttgagtgatcttcatgtattccacgagaaatcaaggcac aggggtctcatggtctcatgaatggctccaccaactgaaggtgtgctccatcggggctgt gagtcacctcacgccaggcagaaaggtctctctgtcaaacatggcttcaaggaaccaggg acctggttcctcccacaggccaggccctgcccctaagtgcaatgggaatatatgcacatg tcacctgtcccaaaatgctgggagatggcacttctgcagatggggaaactgagggaccag cccgaagtcacggggaggggaagactcctacacacagggaggagaagaacccagccgggc tgcaaacgcctgcccttcctcaacgtgcctccggctgtgcccacatcgctccagcagctc tgccttcctcaggcataagccttctcagggcaggggaggcccagggagcggcgctcccat cccaggccgggctgctgagcaagcccctcccctttctcccctcatcctctgacagagtcc acctgaatatttgtcctggagccaggatggaagctccaccaggcccagctaacaacagga accctttcagacgcacttctgggtgcgtactgtgccagtatcacacagacacaagccatg tccttgtcagccatgggatccccaaggtccccatgaggtcacaccagtgggccactggga agggcacttcagatgtggagctcccatgggccaggccctgcgaagtggtcctcctacccc ctcatagccagtcttccctgtgagcctgcaagtgactgtgaatgtgagttccactctgga gctaagacgggctgctgcccccgcaatcagatgtcaggcccatgaagccctccatcatcc cactgcagtcagaataaaatgcagcctccctctggcctccaggtcccaaggccagccccc ctgcctcccaggctcacacctgcccctaacctgtgtccagcccctttcccctggctctgt ctcctgcttcccttgtgttcctccaacctcacctgtctgtctggagtgctcctccccggc tctgcctagctggctccttctcaggcatcagggcctggatccactgtggctcttccaagc ctctgcacttggagtgcctcagccccgtggttgaggagtgccccaaccctgtgaccctct agcaagcatcctaggaattccgtccctccccagcactgatatgaccatcgtgctgtgaca cGTGTCATCTCCGCCAGAGTTPrimer
|
For commercial licensing of the VISTA Enhancer Browser and its associated data please contact Virginia de la Puente (vtdelapuente@lbl.gov) at the Berkeley Lab's Innovation and Partnerships Office.